Researchers have uncovered a link between COVID-19 and blood markers linked to faulty proteins in the brain.<\/b><\/p>\n
In an analysis led by researchers at Imperial College London and the UK Dementia Research Institute, scientists found that people who had previously had COVID-19 were more likely to have increased levels of biomarkers linked to faulty amyloid proteins \u2013 a known hallmark for Alzheimer\u2019s disease.<\/p>\n
On average, the effects were comparable to four years of ageing with the greatest effects seen in those hospitalised with severe COVID-19 or with underlying risk factors for dementia such as smoking or high blood pressure.<\/p>\n
According to the researchers, the findings suggest that mild or moderate COVID-19 may accelerate biological processes that contribute to the buildup of disease-promoting amyloid in the brain. The new results raise the possibility that COVID-19 might contribute to an increase in later risks of developing Alzheimer\u2019s disease.<\/p>\n","protected":false},"excerpt":{"rendered":"
Researchers have uncovered a link between COVID-19 and blood markers linked to faulty proteins in the brain.<\/b><\/p>\n
In an analysis led by researchers at Imperial College London and the UK Dementia Research Institute, scientists found that people who had previously had COVID-19 were more likely to have increased levels of biomarkers linked to faulty amyloid proteins \u2013 a known hallmark for Alzheimer\u2019s disease.<\/p>\n